卵巢癌
医学
肿瘤科
内科学
癌症研究
上皮性卵巢癌
癌症
结合
卵巢
临床试验
临床研究阶段
生物信息学
卵巢癌
卵巢癌
化疗
出处
期刊:Cancer Discovery
[American Association for Cancer Research]
日期:2026-04-21
卷期号:: OF1-OF1
标识
DOI:10.1158/2159-8290.cd-nw2026-0044
摘要
ABSTRACT: For patients with advanced platinum-resistant ovarian cancer, treatment options remain limited, but new agents are emerging. One is QLS5132, an antibody-drug conjugate targeting CLDN6; early data from a phase I trial indicates that it has a favorable safety profile and appears active in this disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI